Our study aimed to investigate the expression of GrB in peripheral blood mononuclear cells (PBMC), including CTLs and NK cells in patients with ovarian or lung cancer as well as with PNS. This evidence concerns the gene GZMB and paraneoplastic neurologic syndrome.